SAMANTHA MOGAVERO: Open Payments
NPI 1902360183 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 40 payments from 6 companies in 2025. Trend: 2023 $626 · 2024 $478 · 2025 $994
Food & beverage: $810Education: $184
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $415 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $274 |
| ABBVIE INC. | 16 | $219 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, UZEDY, ABILIFY ASIMTUFII, Qelbree, FANAPT.
Industry payments across NY — which companies pay providers there.
